Researchers discover new potential antibody treatment for asthma – Medical Xpress


CTV News

Researchers discover new potential antibody treatment for asthma
Medical Xpress
Researchers at St. Joseph's Healthcare Hamilton and McMaster University have successfully tested an antibody that can improve the quality of life for individuals with asthma by relieving inflammation in the lungs. The research was led by Dr. Gail
Canadian researchers find new way to treat mild asthmaCTV News
Hamilton researchers discover potential asthma treatmentHamilton Spectator

all 3 news articles »

View full post on asthma – Google News

Researchers Find Potential Target for Drug to Treat Allergic Asthma – Ohio State University

Researchers Find Potential Target for Drug to Treat Allergic Asthma
Ohio State University
COLUMBUS, Ohio – An enzyme that helps maintain immune system function by “throwing away” a specific protein has a vital role in controlling symptoms of allergic asthma, new research in mice suggests. The finding suggests that this enzyme, called Cbl-b, …

View full post on asthma – Google News

Researchers Find Potential Target for Drug to Treat Allergic Asthma – Newswise (press release)

Researchers Find Potential Target for Drug to Treat Allergic Asthma
Newswise (press release)
Newswise — COLUMBUS, Ohio – An enzyme that helps maintain immune system function by “throwing away” a specific protein has a vital role in controlling symptoms of allergic asthma, new research in mice suggests. The finding suggests that this enzyme, 

and more »

View full post on asthma – Google News

Researchers find potential target for drug to treat allergic asthma – Medical Xpress

Researchers find potential target for drug to treat allergic asthma
Medical Xpress
The finding suggests that this enzyme, called Cbl-b, could be a target for drugs used to treat allergic asthma and other autoimmune disorders. This new study, led by Ohio State University researchers, is the first to link Cbl-b to allergic asthma in an

and more »

View full post on asthma – Google News

Bench-to-Bedside Asthma Research to Study Potential Biomarker – Newswise (press release)

Bench-to-Bedside Asthma Research to Study Potential Biomarker
Newswise (press release)
Newswise — OMAHA, Neb. – What started as basic cancer research at Creighton University has yielded promising results for diagnosing and treating asthma – and the National Institutes of Health (NIH) agrees, investing nearly $1.5 million in Creighton to

View full post on asthma – Google News

UPDATE 1-Regeneron, Sanofi asthma drug seen as potential game changer – Reuters


Investorplace.com

UPDATE 1-Regeneron, Sanofi asthma drug seen as potential game changer
Reuters
May 21 (Reuters) – A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for patients with moderate to severe disease
New Asthma Drug Generates Excitement For Patients — And Its MakerForbes
Antibody Gets High Marks for Asthma Control – MedPage TodayMedPage Today
Monoclonal Antibody Dupilumab Safe And Effective In Asthma Phase IIa TrialScience 2.0
Investorplace.com –Fox Business –Nature World News
all 17 news articles »

View full post on asthma – Google News

Study Finds Potential Treatment For Some Asthma Sufferers – Houston Chronicle (blog)


Medical Daily

Study Finds Potential Treatment For Some Asthma Sufferers
Houston Chronicle (blog)
According to a news release from the University of Pittsburgh Medicial Center, recent estimates suggest that 24.6 million Americans have asthma and 10 to 20 percent don't have optimal control of their symptoms despite modern medicines, according to
Allergic Asthma Treatment, Dupilumab, Successful In Phase II TrialsMedical Daily
Pitt researchers explore alternate asthma treatmentsPittsburgh Business Times

all 3 news articles »

View full post on asthma – Google News

Regeneron, Sanofi asthma drug seen as potential game changer – Reuters

Regeneron, Sanofi asthma drug seen as potential game changer
Reuters
(Reuters) – A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for patients with moderate to severe disease, researchers
Monoclonal antibody appears effective and safe in asthma Phase IIa trialEurekAlert (press release)
Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of PR Newswire (press release)

all 4 news articles »

View full post on asthma – Google News

Researchers identify a potential new risk for sleep apnea: Asthma – EurekAlert! – EurekAlert (press release)

Researchers identify a potential new risk for sleep apnea: Asthma – EurekAlert!
EurekAlert (press release)
ATS 2013, PHILADELPHIA ? Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin
Asthmatics At Higher Risk For Sleep Apnea, Study FindsMedical Daily

all 2 news articles »

View full post on asthma – Google News

La Peer Doctor Talks Potential HIV Cure, Link Between BPA and Asthma – PR Web (press release)


PR Web (press release)

La Peer Doctor Talks Potential HIV Cure, Link Between BPA and Asthma
PR Web (press release)
“Incidence of asthma in our country is increasing, and we don't know why,” said Dr. Ahluwalia, pointing to studies linking the BPA mothers are consuming with a rise in asthma rates among young children. “We add a lot of these chemicals to make our

and more »

View full post on asthma – Google News